Bevacizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant

The bevacizumab biosimilar, L234A L235A P329G (LALAPG) Fc silent mutant, can be used for ELISA, neutralization, in vitro and in vivo functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by bevacizumab. The research grade bevacizumab biosimilar protein, L234A L235A P329G (LALAPG) Fc silent mutant, is for research use only.

Synonyms: VEGF, VEGF-A, vascular endothelial growth factor A, anti-VEGF